“CSOFT Goes For A Soft Touch In Scaling Outside China” – Article about CSOFT written by Rebecca Fannin of Forbes Magazine

2013年7月19日

One of the more interesting aspects of my role covering innovation trends in emerging markets is the opportunity to see companies close-up as they scale. Such was my recent experience attending a summit held by CSOFT International in Beijing and Sanya, the Hawaii of China.

CSOFT was celebrating its 10th anniversary with a two-day program of experts speaking about globalization trends in the so-called localization business in which it operates. One clear takeaway? I am sure that CSOFT would never have become a profitable player in this market without the visionary leadership of its very determined president and CEO, Shunee Yee (pictured with me).

Sounding a bit like Alibaba’s Jack Ma, Shunee says “the sky’s the limit” on her startup’s potential, which she envisions becoming a $1 billion business. The company’s nifty-looking headquarters at Beijing’s sleek, new World Finance Centre is a symbol of her ambitions.

Click here to read the whole entry.

About CSOFT Health Sciences

CSOFT Health Sciences, leaders in clinical trial localization, provides AI/ML-enabled medical translation services for all phases of the drug and medical device product lifecycle, from development to post-launch. We also specialize in DCT solutions, linguistic validation, and CTD/eCTD submissions with the FDA, EMA, and NMPA. Our operations are certified in ISO 17100:2015, ISO 9001:2015, and ISO 13485:2016, ensuring our customized solutions meet the rigorous regulatory requirements of MMA, NDA, CTA, and Medical Device Application submissions. www.csoftintl.com

Media Contacts

Nikki Andrews (U.S./Europe)

Phone: +1 (617) 263-8950
Sidebar:
有任何问题?

欢迎随时与我们联系。